231 related articles for article (PubMed ID: 32013836)
1. Therapeutic Effects of Curcumin against Bladder Cancer: A Review of Possible Molecular Pathways.
Ashrafizadeh M; Yaribeygi H; Sahebkar A
Anticancer Agents Med Chem; 2020; 20(6):667-677. PubMed ID: 32013836
[TBL] [Abstract][Full Text] [Related]
2. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs.
Wang M; Jiang S; Zhou L; Yu F; Ding H; Li P; Zhou M; Wang K
Int J Biol Sci; 2019; 15(6):1200-1214. PubMed ID: 31223280
[TBL] [Abstract][Full Text] [Related]
3. Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.
Yang Y; Deng S; Zeng Q; Hu W; Chen T
Dalton Trans; 2016 Nov; 45(46):18465-18475. PubMed ID: 27711726
[TBL] [Abstract][Full Text] [Related]
4. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets of curcumin for cancer therapy: an updated review.
Kasi PD; Tamilselvam R; Skalicka-Woźniak K; Nabavi SF; Daglia M; Bishayee A; Pazoki-Toroudi H; Nabavi SM
Tumour Biol; 2016 Oct; 37(10):13017-13028. PubMed ID: 27468716
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Applications of Curcumin and its Novel Formulations in the Treatment of Bladder Cancer: A Review of Current Evidence.
Pourhanifeh MH; Mottaghi R; Razavi ZS; Shafiee A; Hajighadimi S; Mirzaei H
Anticancer Agents Med Chem; 2021; 21(5):587-596. PubMed ID: 32767956
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway.
Tian B; Zhao Y; Liang T; Ye X; Li Z; Yan D; Fu Q; Li Y
J Drug Target; 2017 Aug; 25(7):626-636. PubMed ID: 28286973
[TBL] [Abstract][Full Text] [Related]
8. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
Kunnumakkara AB; Bordoloi D; Harsha C; Banik K; Gupta SC; Aggarwal BB
Clin Sci (Lond); 2017 Aug; 131(15):1781-1799. PubMed ID: 28679846
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy for advanced urothelial cancer of the bladder: where do we stand?
Zhu Z; Shen Z; Xu C
Anticancer Agents Med Chem; 2012 Nov; 12(9):1081-7. PubMed ID: 22583418
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells.
Zhang L; Yang G; Zhang R; Dong L; Chen H; Bo J; Xue W; Huang Y
Int J Oncol; 2018 Aug; 53(2):515-526. PubMed ID: 29901071
[TBL] [Abstract][Full Text] [Related]
11. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
Chen F; Chen X; Yang D; Che X; Wang J; Li X; Zhang Z; Wang Q; Zheng W; Wang L; Wang X; Song X
Oncol Rep; 2016 Jul; 36(1):165-72. PubMed ID: 27177091
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of curcumin action: signal transduction.
Shehzad A; Lee YS
Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697
[TBL] [Abstract][Full Text] [Related]
13. Curcumin Inhibits Bladder Cancer by Inhibiting Invasion via AKT/MMP14 Pathway.
Wang K; Xiao W; Zeng Q
Discov Med; 2024 Jan; 36(180):71-81. PubMed ID: 38273747
[TBL] [Abstract][Full Text] [Related]
14. Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells.
Park C; Kim GY; Kim GD; Choi BT; Park YM; Choi YH
Oncol Rep; 2006 May; 15(5):1225-31. PubMed ID: 16596191
[TBL] [Abstract][Full Text] [Related]
15. Molecular targets of curcumin in breast cancer (Review).
Song X; Zhang M; Dai E; Luo Y
Mol Med Rep; 2019 Jan; 19(1):23-29. PubMed ID: 30483727
[TBL] [Abstract][Full Text] [Related]
16. Effects of curcumin in an orthotopic murine bladder tumor model.
Leite KR; Chade DC; Sanudo A; Sakiyama BY; Batocchio G; Srougi M
Int Braz J Urol; 2009; 35(5):599-606; discussion 606-7. PubMed ID: 19860939
[TBL] [Abstract][Full Text] [Related]
17. Mitigation of aflatoxin B1- and sodium arsenite-induced cytotoxicities in HUC-PC urinary bladder cells by curcumin and Khaya senegalensis.
Olugbami JO; Damoiseaux R; Odunola OA; Gimzewski JK
J Basic Clin Physiol Pharmacol; 2020 Apr; 31(4):. PubMed ID: 32324162
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits bladder cancer stem cells by suppressing Sonic Hedgehog pathway.
Wang D; Kong X; Li Y; Qian W; Ma J; Wang D; Yu D; Zhong C
Biochem Biophys Res Commun; 2017 Nov; 493(1):521-527. PubMed ID: 28870814
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tobacco smoke-induced bladder MAPK activation and epithelial-mesenchymal transition in mice by curcumin.
Liang Z; Xie W; Wu R; Geng H; Zhao L; Xie C; Li X; Zhu M; Zhu W; Zhu J; Huang C; Ma X; Wu J; Geng S; Zhong C; Han H
Int J Clin Exp Pathol; 2015; 8(5):4503-13. PubMed ID: 26191140
[TBL] [Abstract][Full Text] [Related]
20. Hitting the golden TORget: curcumin's effects on mTOR signaling.
Beevers CS; Zhou H; Huang S
Anticancer Agents Med Chem; 2013 Sep; 13(7):988-94. PubMed ID: 23272912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
